Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methylpiperidinium Bromide
2. Fenpipramide Methobromide
3. Fenpiverinium
4. Resantin
1. 125-60-0
2. Fenpiverinium Bromide [inn]
3. 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methylpiperidinium Bromide
4. Fenpipramide Bromomethylate
5. Resantin
6. 36479ua8gl
7. 1-(4-amino-4-oxo-3,3-diphenylbutyl)-1-methylpiperidinium Bromide
8. 4-(1-methylpiperidin-1-ium-1-yl)-2,2-diphenylbutanamide;bromide
9. Hoechst 12494
10. Dsstox_cid_26484
11. Dsstox_rid_81655
12. Dsstox_gsid_46484
13. Fenpiverinium Bromide (inn)
14. 12494 Hoechst
15. Cas-125-60-0
16. Bromuro De Fempiverinio [inn-spanish]
17. Fenpiverinii Bromidum
18. Bromuro De Fempiverinio
19. Bromure De Fenpiverinium
20. Fenpiverinii Bromidum [inn-latin]
21. Ncgc00164621-01
22. Einecs 204-744-9
23. U 0385
24. Bromure De Fenpiverinium [inn-french]
25. Unii-36479ua8gl
26. Fenpiveriniumbromid
27. Diphenyl-piperidino-aethyl-acetamid-brommethylat [german]
28. 1-((3-carbamoyl-3,3-diphenyl)propyl)-1-methylpiperidinium Bromid
29. Diphenyl-piperidino-aethyl-acetamid-brommethylat
30. Schembl23654
31. Fenpiverinium Bromide- Bio-x
32. Mls001423990
33. Chembl2106138
34. Dtxsid0046484
35. Fenpiverinium Bromide [mi]
36. Hms2051k06
37. Hms3393g04
38. Tox21_112240
39. Piperidinium, 1-(3-carbamoyl-3,3-diphenylpropyl)-1-methyl-, Bromide
40. Fenpiverinium Bromide [mart.]
41. Akos030239816
42. Fenpiverinium Bromide [who-dd]
43. Piperidinium, 1-(4-amino-4-oxo-3,3-diphenylbutyl)-1-methyl-, Bromide
44. Tox21_112240_1
45. Ccg-100844
46. Nc00084
47. Ncgc00164621-02
48. Bf164453
49. Smr000469284
50. Ft-0626404
51. D07070
52. Q27256524
Molecular Weight | 417.4 g/mol |
---|---|
Molecular Formula | C22H29BrN2O |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 6 |
Exact Mass | 416.14633 g/mol |
Monoisotopic Mass | 416.14633 g/mol |
Topological Polar Surface Area | 43.1 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 411 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Date of Issue : 2019-07-22
Valid Till : 2022-07-22
Written Confirmation Number : WC-0139
Address of the Firm :
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Market Place
ANALYTICAL
ABOUT THIS PAGE
A Fenpiverinium Bromide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fenpiverinium Bromide, including repackagers and relabelers. The FDA regulates Fenpiverinium Bromide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fenpiverinium Bromide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fenpiverinium Bromide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fenpiverinium Bromide supplier is an individual or a company that provides Fenpiverinium Bromide active pharmaceutical ingredient (API) or Fenpiverinium Bromide finished formulations upon request. The Fenpiverinium Bromide suppliers may include Fenpiverinium Bromide API manufacturers, exporters, distributors and traders.
click here to find a list of Fenpiverinium Bromide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Fenpiverinium Bromide written confirmation (Fenpiverinium Bromide WC) is an official document issued by a regulatory agency to a Fenpiverinium Bromide manufacturer, verifying that the manufacturing facility of a Fenpiverinium Bromide active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Fenpiverinium Bromide APIs or Fenpiverinium Bromide finished pharmaceutical products to another nation, regulatory agencies frequently require a Fenpiverinium Bromide WC (written confirmation) as part of the regulatory process.
click here to find a list of Fenpiverinium Bromide suppliers with Written Confirmation (WC) on PharmaCompass.
Fenpiverinium Bromide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fenpiverinium Bromide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fenpiverinium Bromide GMP manufacturer or Fenpiverinium Bromide GMP API supplier for your needs.
A Fenpiverinium Bromide CoA (Certificate of Analysis) is a formal document that attests to Fenpiverinium Bromide's compliance with Fenpiverinium Bromide specifications and serves as a tool for batch-level quality control.
Fenpiverinium Bromide CoA mostly includes findings from lab analyses of a specific batch. For each Fenpiverinium Bromide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fenpiverinium Bromide may be tested according to a variety of international standards, such as European Pharmacopoeia (Fenpiverinium Bromide EP), Fenpiverinium Bromide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fenpiverinium Bromide USP).
LOOKING FOR A SUPPLIER?